Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen
Top
Journal of Autism and Developmental Disorders
Gepubliceerd in:

01-06-2015 | Original Paper

Multidisciplinary Assessment and Treatment of Self-Injurious Behavior in Autism Spectrum Disorder and Intellectual Disability: Integration of Psychological and Biological Theory and Approach

Auteurs: Noha F. Minshawi, Sarah Hurwitz, Danielle Morriss, Christopher J. McDougle

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 6/2015

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

The objective of this review is to consider the psychological (largely behavioral) and biological [neurochemical, medical (including genetic), and pharmacological] theories and approaches that contribute to current thinking about the etiology and treatment of self-injurious behavior (SIB) in individuals with autism spectrum disorder and/or intellectual disability. Algorithms for the assessment and treatment of SIB in this context, respectively, from a multidisciplinary, integrative perspective are proposed and challenges and opportunities that exist in clinical and research settings are discussed.
vorige artikel Improving Psychosexual Knowledge in Adolescents with Autism Spectrum Disorder: Pilot of the Tackling Teenage Training Program
volgende artikel Increased Exposure to Rigid Routines can Lead to Increased Challenging Behavior Following Changes to Those Routines
Literatuur
Aboitiz, F., Scheibel, A. B., Fisher, R. S., & Zaidel, E. (1992). Individual differences in brain asymmetries and fiber composition in the human corpus callosum. Brain Research, 598(1), 154–161.PubMed
Adamson, W. C., Nellis, B. P., Runge, G., Cleland, C., & Killian, E. (1958). Use of tranquilizers for mentally deficient patients. Archives of Pediatrics and Adolescent Medicine, 96(2), 159–164.
Aghajanian, G. K., & Sanders-Bush, E. (2002). Serotonin. In K. L. Davis, D. Charney, J. T. Coyle, & C. Nemeroff (Eds.), Neuropsychopharmacology: The fifth generation of progress (pp. 15–34). Philidelphia, PA: Lippincott Williams & Wilkins.
Alexander, A. L., Lee, J. E., Lazar, M., Boudos, R., DuBray, M. B., Oakes, T. R., et al. (2007). Diffusion tensor imaging of the corpus callosum in autism. Neuroimage, 34(1), 61–73.PubMed
Aman, M. G. (1993). Efficacy of psychotropic drugs for reducing self-injurious behavior in the developmental disabilities. Annals of Clinical Psychiatry, 5(3), 171–188.PubMed
Aman, M. G., De Smedt, G., Derivan, A., Lyons, B., & Findling, R. L. (2002). Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. The American Journal of Psychiatry, 159(8), 1337–1346.PubMed
Aman, M. G., Kasper, W., Manos, G., Mathew, S., Marcus, R., Owen, R., et al. (2010). Line-item analysis of the Aberrant Behavior Checklist: Results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder. Journal of Child and Adolescent Psychopharmacology, 20(5), 415–422.PubMed
Aman, M. G., & Madrid, A. (1999). Atypical antipsychotics in persons with developmental disabilities. Mental Retardation and Developmental Disabilities Research Reviews, 5(4), 253–263.
Aman, M. G., McDougle, C. J., Scahill, L., Handen, B., Arnold, L. E., Johnson, C., et al. (2009). Medication and parent training in children with pervasive developmental disorders and serious behavior problems: Results from a randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 48(12), 1143–1154.PubMed
Aman, M. G., Teehan, C. J., White, A. J., Turbott, S. H., & Vaithianathan, C. (1989). Haloperidol treatment with chronically medicated residents: Dose effects on clinical behavior and reinforcement contingencies. American Journal of Mental Retardation, 93(4), 452–460.PubMed
Aman, M. G., & White, A. J. (1988). Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents. Journal of Autism and Developmental Disorders, 18(3), 355–366.PubMed
Anderson, L. T., & Ernst, M. (1994). Self-injury in Lesch-Nyhan disease. Journal of Autism and Developmental Disorders, 24(1), 67–81.PubMed
Anderson, G. M., Gutknecht, L., Cohen, D. J., Brailly-Tabard, S., Cohen, J. H., Ferrari, P., et al. (2002). Serotonin transporter promoter variants in autism: Functional effects and relationship to platelet hyperserotonemia. Molecular Psychiatry, 7(8), 831–836.PubMed
Anderson, L. T., Herrmann, L., & Dancis, J. (1976). The effect of L-5-hydroxytryptophan on self-mutilation in Lesch-Nyhan disease: A negative report. Neuropadiatrie, 7(4), 439–442.PubMed
Arnold, L. E., Vitiello, B., McDougle, C. J., Scahill, L., Shah, B., Gonzales, N. M., et al. (2003). Parent-defined target symptoms respond to risperidone in RUPP autism study: Customer approach to clinical trials. Journal of the American Academy of Child and Adolescent Psychiatry, 42(12), 1443–1450.PubMed
Arron, K., Oliver, C., Moss, J., Berg, K., & Burbidge, C. (2011). The prevalence and phenomenology of self-injurious and aggressive behaviour in genetic syndromes. Journal of Intellectual Disability Research, 55(2), 109–120.PubMed
Baghdadli, A., Pascal, C., Grisi, S., & Aussilloux, C. (2003). Risk factors for self-injurious behaviours among 222 young children with autistic disorders. Journal of Intellectual Disability Research, 47(8), 622–627.PubMed
Baghdadli, A., Picot, M. C., Pry, R., Michelon, C., Burzstejn, C., Lazartigues, A., et al. (2008). What factors are related to a negative outcome of self-injurious behaviour during childhood in pervasive developmental disorders? Journal of Applied Research in Intellectual Disabilities, 21(2), 142–149.
Baldessarini, R. J., & Frankenburg, F. R. (1991). Clozapine: A novel antipsychotic agent. The New England Journal of Medicine, 324(11), 746–754.PubMed
Barrera, F. J., Violo, R. A., & Graver, E. E. (2007). On the form and function of severe self-injurious behavior. Behavioral Interventions, 22(1), 5–33.
Baumeister, A. A., & Frye, G. D. (1984). Self-injurious behavior in rats produced by intranigral microinjection of GABA agonists. Pharmacology, Biochemistry and Behavior, 21(1), 89–95.PubMed
Baumeister, A. A., & Frye, G. D. (1985). The biochemical basis of the behavioral disorder in the Lesch-Nyhan syndrome. Neuroscience and Biobehavioral Reviews, 9(2), 169–178.PubMed
Baxter, C., Cummins, R. A., & Yiolitis, L. (2000). Parental stress attributed to family members with and without intellectual disability: A longitudinal study. Journal of Intellectual and Developmental Disability, 25(2), 105–118.
Beadle-Brown, J., Murphy, G., & Wing, L. (2005). Long-term outcome for people with severe intellectual disabilities: Impact of social impairment. American Journal of Mental Retardation, 110(1), 1–12.PubMed
Bear, D., Levin, K., Blumer, D., Chetham, D., & Ryder, J. (1982). Interictal behaviour in hospitalised temporal lobe epileptics: Relationship to idiopathic psychiatric syndromes. Journal of Neurology, Neurosurgery and Psychiatry, 45(6), 481–488.PubMedCentralPubMed
Bitsika, V., & Sharpley, C. F. (2004). Stress, anxiety and depression among parents of children with autism spectrum disorder. Australian Journal of Guidance and Counselling, 14(2), 151–161.
Blacher, J., Lopez, S., Shapiro, J., & Fusco, J. (1997). Contributions to depression in latina mothers with and without children with retardation: Implications for caregiving. Family Relations, 46(4), 325–334.
Blake, B. L., Muehlmann, A. M., Egami, K., Breese, G. R., Devine, D. P., & Jinnah, H. A. (2007). Nifedipine suppresses self-injurious behaviors in animals. Developmental Neuroscience, 29(3), 241–250.PubMedCentralPubMed
Blatt, G. J. (2011). The GABA system in autism. In E. Hollander, A. Kolevzon, & J. T. Coyle (Eds.), Textbook of autism spectrum disorders (pp. 323–326). Washington, DC: American Psychiatric Publishing Inc.
Blatt, G. J., Fitzgerald, C. M., Guptill, J. T., Booker, A. B., Kemper, T. L., & Bauman, M. L. (2001). Density and distribution of hippocampal neurotransmitter receptors in autism: An autoradiographic study. Journal of Autism and Developmental Disorders, 31(6), 537–543.PubMed
Bloch, M. R., Elliott, M., Thompson, H., & Koran, L. M. (2001). Fluoxetine in pathologic skin-picking: Open-label and double-blind results. Psychosomatics, 42(4), 314–319.PubMed
Blumer, D. (2000). Dysphoric disorders and paroxysmal affects: Recognition and treatment of epilepsy-related psychiatric disorders. Harvard Review of Psychiatry, 8(1), 8–17.PubMed
Borrero, J. C., Vollmer, T. R., Wright, C. S., Lerman, D. C., & Kelley, M. E. (2002). Further evaluation of the role of protective equipment in the functional analysis of self-injurious behavior. Journal of Applied Behavior Analysis, 35(1), 69–72.PubMedCentralPubMed
Bosch, J., Van Dyke, C., Smith, S. M., & Poulton, S. (1997). Role of medical conditions in the exacerbation of self-injurious behavior: An exploratory study. Mental Retardation, 35(2), 124–130.PubMed
Boyer, W. F., & Feighner, J. P. (1992). An overview of paroxetine. The Journal of Clinical Psychiatry, 53, 3–6.PubMed
Brahm, N. C., Fast, G. A., & Brown, R. C. (2008). Buspirone for autistic disorder in a woman with an intellectual disability. The Annals of Pharmacotherapy, 42(1), 131–137.PubMed
Brandt, B. R., & Rosen, I. (1998). Impaired peripheral somatosensory function in children with Prader-Willi syndrome. Neuropediatrics, 29(3), 124–126.PubMed
Breau, L. M., Camfield, C. S., Symons, F. J., Bodfish, J. W., Mackay, A., Finley, G. A., et al. (2003). Relation between pain and self-injurious behavior in nonverbal children with severe cognitive impairments. The Journal of Pediatrics, 142(5), 498–503.PubMed
Breau, L. M., McGrath, P. J., Camfield, C., Rosmus, C., & Finley, G. A. (2000). Preliminary validation of an observational pain checklist for persons with cognitive impairments and inability to communicate verbally. Developmental Medicine and Child Neurology, 42(9), 609–616.PubMed
Breese, G. R., Baumeister, A. A., McCown, T. J., Emerick, S. G., Frye, G. D., Crotty, K., et al. (1984). Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: Relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. The Journal of Pharmacology and Experimental Therapeutics, 231(2), 343–354.PubMedCentralPubMed
Breese, G. R., Criswell, H. E., Duncan, G. E., & Mueller, R. A. (1990). A dopamine deficiency model of Lesch-Nyhan disease: The neonatal-6-OHDA-lesioned rat. Brain Research Bulletin, 25(3), 477–484.PubMed
Bruhl, H. H., Fielding, L., Joyce, M., Peters, W., & Wieseler, N. (1982). Thirty-month demonstration project for treatment of self-injurious behavior in severely retarded individuals. Monographs of the American Association on Mental Deficiency, 5, 191–275.PubMed
Brylewski, J., & Wiggs, L. (1999). Sleep problems and daytime challenging behaviour in a community-based sample of adults with intellectual disability. Journal of Intellectual Disability Research, 43(6), 504–512.PubMed
Buitelaar, J. K. (1993). Self-injurious behaviour in retarded children: Clinical phenomena and biological mechanisms. Acta Paedopsychiatrica, 56(2), 105–111.PubMed
Butler, M. G., Bittel, D. C., Kibiryeva, N., Talebizadeh, Z., & Thompson, T. (2004). Behavioral differences among subjects with Prader-Willi syndrome and type I or type II deletion and maternal disomy. Pediatrics, 113(3), 565–573.PubMed
Campbell, M., Anderson, L. T., Small, A. M., Adams, P., Gonzalez, N. M., & Ernst, M. (1993). Naltrexone in autistic children: Behavioral symptoms and attentional learning. Journal of the American Academy of Child and Adolescent Psychiatry, 32(6), 1283–1291.PubMed
Cancela, L. M., Artinian, J., & Fulginiti, S. (1988). Opioid influence on some aspects of stereotyped behavior induced by repeated amphetamine treatment. Pharmacology, Biochemistry and Behavior, 30(4), 899–904.PubMed
Canitano, R. (2006). Self injurious behavior in autism: Clinical aspects and treatment with risperidone. Journal of Neural Transmission, 113(3), 425–431.PubMed
Carr, J. E., Coriaty, S., Wilder, D. A., Gaunt, B. T., Dozier, C. L., Britton, L. N., et al. (2000). A review of “noncontingent” reinforcement as treatment for the aberrant behavior of individuals with developmental disabilities. Research in Developmental Disabilities, 21(5), 377–391.PubMed
Carr, E. G., & LeBlanc, L. A. (2003). Functional analysis of problem behavior. In W. Donahue, J. E. Fishers, & S. C. Hayes (Eds.), Cognitive behavior therapy: Applying empirically supported techniques in your practice. Hoboken, NJ: Wiley.
Carr, J. E., Severtson, J. M., & Lepper, T. L. (2009). Noncontingent reinforcement is an empirically supported treatment for problem behavior exhibited by individuals with developmental disabilities. Research in Developmental Disabilities, 30(1), 44–57.PubMed
Carr, E. G., & Smith, C. E. (1995). Biological setting events for self-injury. Mental Retardation and Developmental Disabilities Research Reviews, 1(2), 94–98.
Carr, E. G., Smith, C. E., Giacin, T. A., Whelan, B. M., & Pancari, J. (2003). Menstrual discomfort as a biological setting event for severe problem behavior: Assessment and intervention. American Journal of Mental Retardation, 108(2), 117–133.PubMed
Carroll, M. N., & Lim, R. K. (1960). Observations on the neuropharmacology of morphine and morphinelike analgesia. Archives Internationales de Pharmacodynamie et de Therapie, 125, 383–403.PubMed
Cassidy, S. B., Schwartz, S., Miller, J. L., & Driscoll, D. J. (2012). Prader-Willi syndrome. Genetics in Medicine, 14(1), 10–26.PubMed
Clarke, S., Dunlap, G., & Vaughn, B. (1999). Family-centered, assessment-based intervention to improve behavior during an early morning routine. Journal of Positive Behavior Interventions, 1(4), 235–241.
Codling, M., & MacDonald, N. (2009). Epilepsy: Implications for people with profound intellectual and multiple disabilities. In J. Pawlyn & S. Carnaby (Eds.), Profound intellectual and multiple disabilities: Nursing complex needs (pp. 134–146). Hoboken: Wiley.
Coffey, M. J. (2013). Resolution of self-injury with phenytoin in a man with autism and intellectual disability: The role of frontal lobe seizures and catatonia. Journal of ECT, 29(1), 12–13.
Cohen, S. A., & Underwood, M. T. (1994). The use of clozapine in a mentally retarded and aggressive population. Journal of Clinical Psychiatry, 55(10), 440–444.PubMed
Collins, M. S., & Cornish, K. (2002). A survey of the prevalence of stereotypy, self-injury and aggression in children and young adults with Cri du Chat syndrome. Journal of Intellectual Disability Research, 46(2), 133–140.PubMed
Consoli, A., Cohen, J., Bodeau, N., Guinchat, V., Wachtel, L., & Cohen, D. (2013). Electroconvulsive therapy in adolescents with intellectual disability and severe self-injurious behavior and aggression: A retrospective study. European Child and Adolescent Psychiatry, 22(1), 55–62.PubMed
Conti, F., & Manzoni, T. (1994). The neurotransmitters and postsynaptic actions of callosally projecting neurons. Behavioural Brain Research, 64(1), 37–53.PubMed
Cooper, A. F., & Fowlie, H. C. (1973). Control of gross self-mutilation with lithium carbonate. The British Journal of Psychiatry, 122(568), 370–371.PubMed
Cooper, J. O., Heron, T. E., & Heward, W. L. (2007). Applied behavior analysis. New Jersey: Pearson Education Inc.
Cooper, S. A., Smiley, E., Allan, L. M., Jackson, A., Finlayson, J., Mantry, D., et al. (2009). Adults with intellectual disabilities: Prevalence, incidence and remission of self-injurious behaviour, and related factors. Journal of Intellectual Disability Research, 53(3), 200–216.PubMed
Cornish, K. M., Bramble, D., Munir, F., & Pigram, J. (1999). Cognitive functioning in children with typical cri du chat (5p-) syndrome. Developmental Medicine and Child Neurology, 41(4), 263–266.PubMed
Courtemanche, A., Schroeder, S., Sheldon, J., Sherman, J., & Fowler, A. (2012). Observing signs of pain in relation to self-injurious behaviour among individuals with intellectual and developmental disabilities. Journal of Intellectual Disability Research, 56(5), 501–515.PubMed
Crawford, H. (2009). Dysphagia and people with profound intellectual and multiple disabilities. In J. Pawlyn & S. Carnaby (Eds.), Profound intellectual and multiple disabilities: Nursing complex needs (pp. 236–258). Hoboken: Wiley.
Crockett, C. M., Sackett, G. P., Sandman, C. A., Chicz-DeMet, A., & Bentson, K. L. (2007). Beta-endorphin levels in longtailed and pigtailed macaques vary by abnormal behavior rating and sex. Peptides, 28(10), 1987–1997.PubMedCentralPubMed
Crossland, S., Burns, M., Leach, C., & Quinn, P. (2005). Needs assessment in forensic learning disability. Medicine, Science and the Law, 45(2), 147–153.
Czapinski, P., Blaszczyk, B., & Czuczwar, S. J. (2005). Mechanisms of action of antiepileptic drugs. Current Topics in Medicinal Chemistry, 5(1), 3–14.PubMed
Davanzo, P. A., Belin, T. R., Widawski, M. H., & King, B. H. (1998). Paroxetine treatment of aggression and self-injury in persons with mental retardation. American Journal of Mental Retardation, 102(5), 427–437.PubMed
Davanzo, P. A., & King, B. H. (1996). Open trial lamotrigine in the treatment of self-injurious behavior in an adolescent with profound mental retardation. Journal of Child and Adolescent Psychopharmacology, 6(4), 273–279.PubMed
Davis, K. V., Sprague, R. L., & Werry, J. S. (1969). Stereotyped behavior and activity level in severe retardates: The effect of drugs. American Journal of Mental Deficiency, 73(5), 721–727.PubMed
de Winter, C. F., Jansen, A. A., & Evenhuis, H. M. (2011). Physical conditions and challenging behaviour in people with intellectual disability: A systematic review. Journal of Intellectual Disability Research, 55(7), 675–698.PubMed
Deb, S., Thomas, M., & Bright, C. (2001). Mental disorder in adults with intellectual disability. 2: The rate of behaviour disorders among a community-based population aged between 16 and 64 years. Journal of Intellectual Disability Research, 45(6), 506–514.PubMed
DeLeon, I. G., Fisher, W. W., & Marhefka, J. M. (2004). Decreasing self-injurious behavior associated with awakening in a child with autism and developmental delays. Behavioral Interventions, 19(2), 111–119.
Didden, R., Korzilius, H., & Curfs, L. M. (2007). Skin-picking in individuals with Prader-Willi syndrome: Prevalence, functional assessment, and its comorbidity with compulsive and self-injurious behaviours. Journal of Applied Research in Intellectual Disabilities, 20(5), 409–419.
Dooley, P., Wilczenski, F. L., & Torem, C. (2001). Using an activity schedule to smooth school transitions. Journal of Positive Behavior Interventions, 3(1), 57–61.
Dove, D., Warren, Z., McPheeters, M. L., Taylor, J. L., Sathe, N. A., & Veenstra-VanderWeele, J. (2012). Medications for adolescents and young adults with autism spectrum disorders: A systematic review. Pediatrics, 130(4), 717–726.PubMedCentralPubMed
Duerden, E. G., Oatley, H. K., Mak-Fan, K. M., McGrath, P. A., Taylor, M. J., Szatmari, P., et al. (2012). Risk factors associated with self-injurious behaviors in children and adolescents with autism spectrum disorders. Journal of Autism and Developmental Disorders, 42(11), 2460–2470.PubMed
Duker, P. C. (1975). Use of aversive shock therapy on a retarded girl with self destructive behaviors. Zeitschrift für Klinische Psychologie, 4(1), 38–47.
Duncan, D., Matson, J. L., Bamburg, J. W., Cherry, K. E., & Buckley, T. (1999). The relationship of self-injurious behavior and aggression to social skills in persons with severe and profound learning disability. Research in Developmental Disabilities, 20(6), 441–448.PubMed
Dykens, E. M., Cassidy, S. B., & King, B. H. (1999). Maladaptive behavior differences in Prader-Willi syndrome due to paternal deletion versus maternal uniparental disomy. American Journal on Mental Retardation, 104(1), 67–77.PubMed
Eidelberg, E., & Erspamer, R. (1975). Dopaminergic mechanisms of opiate actions in brain. The Journal of Pharmacology and Experimental Therapeutics, 192(1), 50–57.PubMed
Engel, J., & Berggren, U. (1980). Effects of lithium on behaviour and central monoamines. Acta Psychiatrica Scandinavica, 280, S133–S143.
Ernst, M. (2000). Commentary: Considerations on the characterization and treatment of self-injurious behavior. Journal of Autism and Developmental Disorders, 30(5), 447–450.PubMed
Espie, C. A., Watkins, J., Curtice, L., Espie, A., Duncan, R., Ryan, J. A., et al. (2003). Psychopathology in people with epilepsy and intellectual disability; an investigation of potential explanatory variables. Journal of Neurology, Neurosurgery and Psychiatry, 74(11), 1485–1492.PubMedCentralPubMed
Farber, J. M. (1987). Psychopharmacology of self-injurious behavior in the mentally retarded. Journal of the American Academy of Child and Adolescent Psychiatry, 26(3), 296–302.PubMed
Fatemi, S. H., Folsom, T. D., Reutiman, T. J., & Thuras, P. D. (2009). Expression of GABA(B) receptors is altered in brains of subjects with autism. Cerebellum, 8(1), 64–69.PubMedCentralPubMed
Fisher, W. W., Groff, R. A., & Roane, H. S. (2011). Applied behavior analysis. In W. W. Fisher, C. C. Piazza, & H. S. Roane (Eds.), Handbook of applied behavior analysis (pp. 3–16). New York: Guilford Press.
Fontenot, M. B., Musso, M. W., McFatter, R. M., & Anderson, G. M. (2009). Dose-finding study of fluoxetine and venlafaxine for the treatment of self-injurious and stereotypic behavior in rhesus macaques (Macaca mulatta). Journal of the American Association for Laboratory Animal Science, 48(2), 176–184.PubMedCentralPubMed
Fontenot, M. B., Padgett, E. E, I. I. I., Dupuy, A. M., Lynch, C. R., De Petrillo, P. B., & Higley, J. D. (2005). The effects of fluoxetine and buspirone on self-injurious and stereotypic behavior in adult male rhesus macaques. Comparative Medicine, 55(1), 67–74.PubMed
Garber, H. J., McGonigle, J. J., Slomka, G. T., & Monteverde, E. (1992). Clomipramine treatment of stereotypic behaviors and self-injury in patients with developmental disabilities. Journal of the Amercian Academy of Child and Adolescent Psychiatry, 31(6), 1157–1160.
Glick, I. D., Murray, S. R., Vasudevan, P., Marder, S. R., & Hu, R. J. (2001). Treatment with atypical antipsychotics: New indications and new populations. Journal of Psychiatric Research, 35(3), 187–191.PubMed
Goldstein, M. (1989). Dopaminergic mechanisms in self-inflicting biting behavior. Psychopharmacology Bulletin, 25(3), 349–352.PubMed
Goldstein, M., Anderson, L. T., Reuben, R., & Dancis, J. (1985). Self-mutilation in Lesch-Nyhan disease is caused by dopaminergic denervation. Lancet, 1(8424), 338–339.PubMed
Gossler, A., Schalamon, J., Huber-Zeyringer, A., & Hollwarth, M. E. (2007). Gastroesophageal reflux and behavior in neurologically impaired children. Journal of Pediatric Surgery, 42(9), 1486–1490.PubMed
Granger, P., Biton, B., Faure, C., Vige, X., Depoortere, H., Graham, D., et al. (1995). Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin. Molecular Pharmacology, 47(6), 1189–1196.PubMed
Greenberg, A., & Coleman, M. (1973). Depressed whole blood serotonin levels associated with behavioral abnormalities in the de Lange syndrome. Pediatrics, 52(5), 720–724.PubMed
Gualtieri, C. T. (1989). The differential diagnosis of self-injurious behavior in mentally retarded people. Psychopharmacology Bulletin, 25(3), 358–363.PubMed
Gualtieri, C. T., & Schroeder, S. R. (1989). Pharmacotherapy for self-injurious behavior: Preliminary tests of the D1 hypothesis. Psychopharmacology Bulletin, 25(3), 364–371.PubMed
Guptill, J. T., Booker, A. B., Gibbs, T. T., Kemper, T. L., Bauman, M. L., & Blatt, G. J. (2007). [3H]-flunitrazepam-labeled benzodiazepine binding sites in the hippocampal formation in autism: A multiple concentration autoradiographic study. Journal of Autism and Developmental Disorders, 37(5), 911–920.PubMed
Hammock, R., Levine, W. R., & Schroeder, S. R. (2001). Brief report: Effects of clozapine on self-injurious behavior of two risperidone nonresponders with mental retardation. Journal of Autism and Developmental Disorders, 31(1), 109–113.PubMed
Hanley, H. G., Stahl, S. M., & Freedman, D. X. (1977). Hyperserotonemia and amine metabolites in autistic and retarded children. Archives of General Psychiatry, 34(5), 521–531.PubMed
Hardan, A. Y., Minshew, N. J., & Keshavan, M. S. (2000). Corpus callosum size in autism. Neurology, 55(7), 1033–1036.PubMed
Hassiotis, A., Parkes, C., Jones, L., Fitzgerald, B., & Romeo, R. (2008). Individual characteristics and service expenditure on challenging behaviour for adults with intellectual disabilities. Journal of Applied Research in Intellectual Disabilities, 21(5), 438–445.
Hedges, D., Jeppson, K., & Whitehead, P. (2003). Antipsychotic medication and seizures: A review. Drugs Today, 39(7), 551–557.PubMed
Hellings, J. A., & Warnock, J. K. (1994). Self-injurious behavior and serotonin in Prader-Willi syndrome. Psychopharmacology Bulletin, 30(2), 245–250.PubMed
Hellings, J. A., Weckbaugh, M., Nickel, E. J., Cain, S. E., Zarcone, J. R., Reese, R. M., et al. (2005). A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology, 15(4), 682–692.PubMed
Hollander, E., Wasserman, S., Swanson, E. N., Chaplin, W., Schapiro, M. L., Zagursky, K., et al. (2006). A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder. Journal of Child and Adolescent Psychopharmacology, 16(5), 541–548.PubMed
Holson, R. R., Scallet, A. C., Ali, S. F., Sullivan, P., & Gough, B. (1988). Adrenocortical, beta-endorphin and behavioral responses to graded stressors in differentially reared rats. Physiology & Behavior, 42(2), 125–130.
Horner, R. H., Day, H. M., & Day, J. R. (1997). Using neutralizing routines to reduce problem behaviors. Journal of Applied Behavior Analysis, 30(4), 601–614.PubMedCentralPubMed
Horner, R. H., Day, H. M., Sprague, J. R., & O’Brien, M. (1991). Interspersed requests: A nonaversive procedure for reducing aggression and self-injury during instruction. Journal of Applied Behavior Analysis, 24(2), 265–278.PubMedCentralPubMed
Horsthemke, B., & Wagstaff, J. (2008). Mechanisms of imprinting of the Prader-Willi/Angelman region. American Journal of Medical Genetics, 146A(16), 2041–2052.PubMed
Hurwitz, S., & Minshawi, N. (2012). Methods of defining and observing behaviors. In J. L. Matson (Ed.), Functional assessment for challenging behaviors (pp. 91–103). New York: Springer Science + Business Media LLC.
Iwata, B. A., Dorsey, M. F., Slifer, K. J., & Bauman, K. E. (1994a). Toward a functional analysis of self-injury. Journal of Applied Behavior Analysis, 27(2), 197–209.PubMedCentralPubMed
Iwata, B. A., Pace, G. M., Dorsey, M. F., & Zarcone, J. R. (1994b). The functions of self-injurious behavior: An experimental-epidemiological analysis. Journal of Applied Behavior Analysis, 27(2), 215–240.PubMedCentralPubMed
Iwata, B. A., Pace, G. M., Kalsher, M. J., & Cowdery, G. E. (1990a). Experimental analysis and extinction of self-injurious escape behavior. Journal of Applied Behavior Analysis, 23(1), 11–27.PubMedCentralPubMed
Iwata, B. A., Vollmer, T. R., & Zarcone, J. R. (1990b). The experimental (functional) analysis of behavior disorders: Methodology, applications, and limitations. In A. C. Repp (Ed.), Perspectives on the use of nonaversive and aversive interventions for persons with developmental disabilities (pp. 301–330). Illinois: Sycamore Publishing Company.
Jankovic, J., Caskey, T. C., Stout, J. T., & Butler, I. J. (1988). Lesch-Nyhan syndrome: A study of motor behavior and cerebrospinal fluid neurotransmitters. Annals of Neurology, 23(5), 466–469.PubMed
Janowsky, D. S., Barnhill, L. J., & Davis, J. M. (2003). Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: A retrospective, open-label, naturalistic trial. The Journal of Clinical Psychiatry, 64(10), 1258–1265.PubMed
Janowsky, D. S., Barnhill, L. J., Shetty, M., & Davis, J. M. (2005). Minimally effective doses of conventional antipsychotic medications used to treat aggression, self-injurious and destructive behaviors in mentally retarded adults. Journal of Clinical Psychopharmacology, 25(1), 19–25.PubMed
Jennett, H., Hagopian, L. P., & Beaulieu, L. (2011). Analysis of heart rate and self-injury with and without restraint in an individual with autism. Research in Autism Spectrum Disorders, 5(3), 1110–1118.
Jinnah, H. A., Gage, F. H., & Friedmann, T. (1990). Animal models of Lesch-Nyhan syndrome. Brain Research Bulletin, 25(3), 467–475.PubMed
Jinnah, H. A., Vissar, J. E., Harris, J. C., Verdu, A., Larovere, L., Ceballos-Piscot, I., et al. (2006). Delineation of the motor disorder of Lesch-Nyhan disease. Brain, 129(5), 1201–1217.PubMedCentralPubMed
Jordan, I., Robertson, D., Catani, M., Craig, M., & Murphy, D. (2012). Aripiprazole in the treatment of challenging behaviour in adults with autism spectrum disorder. Psychopharmacology (Berl), 223(3), 357–360.
Kaplan, G. B., & Leite-Morris, B. S. (2002). Introduction to neuronal signaling pathways. In G. B. Kaplan & R. P. Hammer (Eds.), Brain circuitry and signaling in psychiatry (pp. 31–62). Washington, DC: American Psychiatric Publishing Inc.
Kelley, M. E., LaRue, R. H., Roane, H. S., & Gadaire, D. M. (2011). Indirect behavioral assessments: Interviews and rating scales. In W. W. Fisher, C. C. Piazza, & H. S. Roane (Eds.), Handbook of applied behavior analysis (pp. 182–205). New York: Guilford Press.
Kemp, A. S., Fillmore, P. T., Lenjavi, M. R., Lyon, M., Chicz-Demet, A., Touchette, P. E., et al. (2008). Temporal patterns of self-injurious behavior correlate with stress hormone levels in the developmentally disabled. Psychiatry Research, 157(1), 181–189.PubMedCentralPubMed
Kern, L., Gallagher, P., Starosta, K., Hickman, W., & George, M. (2006). Longitudinal outcomes of functional behavioral assessment-based intervention. Journal of Positive Behavior Interventions, 8(2), 67–78.
King, B. H. (1993). Self-injury by people with mental retardation: A compulsive behavior hypothesis. American Journal of Mental Retardation, 98(1), 93–112.PubMed
King, B. H. (2000). Pharmacological treatment of mood disturbances, aggression, and self-injury in persons with pervasive developmental disorders. Journal of Autism and Developmental Disorders, 30(5), 439–445.PubMed
King, B. H., Cromwell, H. C., Lee, H. T., Behrstock, S. P., Schmanke, T., & Maidment, N. T. (1998). Dopaminergic and glutamatergic interactions in the expression of self-injurious behavior. Developmental Neuroscience, 20(2–3), 180–187.PubMed
Knapp, M., Comas-Herrera, A., Astin, J., Beecham, J., & Pendaries, C. (2005). Intellectual disability, challenging behaviour and cost in care accommodation: What are the links? Health and Social Care in the Community, 13(4), 297–306.PubMed
Kraemer, G. W., & Clarke, A. S. (1990). The behavioral neurobiology of self-injurious behavior in rhesus monkeys. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 14, S141–S168.PubMed
La Malfa, G. P., Bertelli, M., Ricca, V., Mannucci, E., & Cabras, P. L. (1997). Fluvoxamine and mental retardation: Clinical use. Italian Journal of Intellective Impairment, 10, 3–6.
Lakin, K. C., Hill, B. K., Hauber, F. A., Bruininks, R. H., & Heal, L. W. (1983). New admissions and readmissions to a national sample of public residential facilities. American Journal of Mental Deficiency, 88, 13–20.
Le Vann, L. J. (1971). Clinical comparison of haloperidol with chlorpromazine in mentally retarded children. American Journal of Mental Deficiency, 75(6), 719–723.PubMed
Leboyer, M., Bouvard, M. P., Launay, J. M., Recasens, C., Plumet, M. H., Waller-Perotte, D., et al. (1993). Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone. L’Encephale, 19(2), 95–102.
Lecavalier, L., Leone, S., & Wiltz, J. (2006). The impact of behaviour problems on caregiver stress in young people with autism spectrum disorders. Journal of Intellectual Disability Research, 50(3), 172–183.PubMed
Leite-Morris, K. A., Fukudome, E. Y., & Kaplan, G. B. (2002). Opiate-induced motor stimulation is regulated by gamma-aminobutyric acid type B receptors found in the ventral tegmental area in mice. Neuroscience Letters, 317(3), 119–122.PubMed
Lejeune, J., Lafourcade, J., Berger, R., Vialatte, J., Boeswillwald, M., Seringe, P., et al. (1963). 3 cases of partial deletion of the short arm of a 5 chromosome. Comptes Rendus Hebdomadaires des Seances de l’Academie des Sciences, 257, 3098–3102.PubMed
Lequia, J., Machalicek, W., & Rispoli, M. J. (2012). Effects of activity schedules on challenging behavior exhibited in children with autism spectrum disorders: A systematic review. Research in Autism Spectrum Disorders, 6(1), 480–492.
Lewis, M. H., Bodfish, J. W., Powell, S. B., Parker, D. E., & Golden, R. N. (1996). Clomipramine treatment for self-injurious behavior of individuals with mental retardation: A double-blind comparison with placebo. American Journal of Mental Retardation, 100(6), 654–665.PubMed
Lewis, M. H., Gluck, J. P., Beauchamp, A. J., Keresztury, M. F., & Mailman, R. B. (1990). Long-term effects of early social isolation in Macaca mulatta: Changes in dopamine receptor function following apomorphine challenge. Brain Research, 513(1), 67–73.PubMed
Lindauer, S. E., DeLeon, I. G., & Fisher, W. W. (1999). Decreasing signs of negative affect and correlated self-injury in an individual with mental retardation and mood disturbances. Journal of Applied Behavior Analysis, 32(1), 103–106.PubMedCentralPubMed
Lindberg, J. S., Iwata, B. A., Roscoe, E. M., Worsdell, A. S., & Hanley, G. P. (2003). Treatment efficacy of noncontingent reinforcement during brief and extended application. Journal of Applied Behavior Analysis, 36(1), 1–19.PubMedCentralPubMed
Lloyd, K. G., Hornykiewicz, O., Davidson, L., Shannak, K., Farley, I., Goldstein, M., et al. (1981). Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. The New England Journal of Medicine, 305(19), 1106–1111.PubMed
Loh, H. H., Brase, D. A., Sampath-Khanna, S., Mar, J. B., Way, E. L., & Li, C. H. (1976). Beta-endorphin in vitro inhibition of striatal dopamine release. Nature, 264(5586), 567–568.PubMed
Lotan, M., Ljunggren, E. A., Johnsen, T. B., Defrin, R., Pick, C. G., & Strand, L. I. (2009). A modified version of the non-communicating children pain checklist-revised, adapted to adults with intellectual and developmental disabilities: Sensitivity to pain and internal consistency. The Journal of Pain, 10(4), 398–407.PubMed
Luiselli, J. K. (1992). Assessment and treatment of self-injury in a deaf-blind child. Journal of Developmental and Physical Disabilities, 4(3), 219–226.
Luiselli, J. K., Cochran, M. L., & Huber, S. A. (2005). Effects of otitis media on a child with autism receiving behavioral intervention for self-injury. Child & Family Behavior Therapy, 27(2), 51–56.
MacLean, W. E., Tervo, R. C., Hoch, J., Tervo, M., & Symons, F. J. (2010). Self-injury among a community cohort of young children at risk for intellectual and developmental disabilities. The Journal of Pediatrics, 157(6), 979–983.PubMed
Magee, S. K., & Ellis, J. (2000). Extinction effects during the assessment of multiple problem behaviors. Journal of Applied Behavior Analysis, 33(3), 313–316.PubMedCentralPubMed
Major, C. A., Kelly, B. J., Novak, M. A., Davenport, M. D., Stonemetz, K. M., & Meyer, J. S. (2009). The anxiogenic drug FG7142 increases self-injurious behavior in male rhesus monkeys (Macaca mulatta). Life Sciences, 85(21–22), 753–758.PubMedCentralPubMed
Mandell, D. S. (2008). Psychiatric hospitalization among children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 38(6), 1059–1065.PubMedCentralPubMed
Marcus, R. N., Owen, R., Kamen, L., Manos, G., McQuade, R. D., Carson, W. H., et al. (2009). A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 48(11), 1110–1119.PubMed
Marholin, D, I. I., Touchette, P. E., & Stewart, R. M. (1979). Withdrawal of chronic chlorpromazine medication: An experimental analysis. Journal of Applied Behavior Analysis, 12(2), 159–171.PubMedCentralPubMed
Matson, J. L., Bamburg, J. W., Mayville, E. A., & Khan, I. (1999). Seizure disorders in people with intellectual disability: An analysis of differences in social functioning, adaptive functioning and maladaptive behaviours. Journal of Intellectual Disability Research, 43(6), 531–539.PubMed
Matson, J. L., & LoVullo, S. V. (2008). A review of behavioral treatments for self-injurious behaviors of persons with autism spectrum disorders. Behavior Modification, 32(1), 61–76.PubMed
Matthews, T., Weston, N., Baxter, H., Felce, D., & Kerr, M. (2008). A general practice-based prevalence study of epilepsy among adults with intellectual disabilities and of its association with psychiatric disorder, behaviour disturbance and career stress. Journal of Intellectual Disability Research, 52(2), 163–173.PubMed
McDonough, M., Hillery, J., & Kennedy, N. (2000). Olanzapine for chronic, stereotypic self-injurious behaviour: A pilot study in seven adults with intellectual disability. Journal of Intellectual Disability Research, 44(6), 677–684.PubMed
McDougle, C. J. (2013). Sounding a wake-up call: Improving the lives of adults with autism. Journal of the American Academy of Child and Adolescent Psychiatry, 52(6), 566–568.PubMed
McDougle, C. J., Naylor, S. T., Cohen, D. J., Aghajanian, G. K., Heninger, G. R., & Price, L. H. (1996a). Effects of tryptophan depletion in drug-free adults with autistic disorder. Archives of General Psychiatry, 53(11), 993–1000.PubMed
McDougle, C. J., Naylor, S. T., Cohen, D. J., Volkmar, F. R., Heninger, G. R., & Price, L. H. (1996b). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 53(11), 1001–1008.PubMed
McElroy, S. L., Keck, P. E., Pope, H. G., & Hudson, J. I. (1989). Valproate in psychiatric disorders: Literature review and clinical guidelines. The Journal of Clinical Psychiatry, 50, S23–S29.
McManaman, J., & Tam, D. A. (1999). Gabapentin for self-injurious behavior in Lesch-Nyhan syndrome. Pediatric Neurology, 20(5), 381–382.PubMed
McNally, G. P., & Akil, H. (2002). Endogenous opioid peptides and their receptors: Overview and function in pain modulation. In K. L. Davis, D. Charney, J. T. Coyle, & C. Nemeroff (Eds.), Neuropsychopharmacology: The fifth generation of progress (pp. 35–46). New York: Lippincott Williams Wilkins.
Mesibov, G. B., Browder, D. M., & Kirkland, C. (2002). Using individualized schedules as a component of positive behavioral support for students with developmental disabilities. Journal of Positive Behavior Interventions, 4(2), 73–79.
Micev, V., & Lynch, D. M. (1974). Effect of lithium on disturbed severely mentally retarded patients. The British Journal of Psychiatry, 125(584), 110.PubMed
Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., et al. (2010). Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. American Journal of Human Genetics, 86(5), 749–764.PubMedCentralPubMed
Miyamoto, S., Duncan, G. E., Goff, D. C., & Lieberman, J. A. (2002). Therapeutics of schizophrenia. In K. L. Davis, D. Charney, J. T. Coyle, & C. Nemeroff (Eds.), Neuropsychopharmacology: The fifth generation of progress (pp. 777–797). Philidelphia, PA: Lippincott Williams & Wilkins.
Mizuno, T. I., & Yugari, Y. (1974). Letter: Self mutilation in Lesch-Nyhan syndrome. Lancet, 1(7860), 761.PubMed
Mizuno, T., & Yugari, Y. (1975). Prophylactic effect of L-5-hydroxytryptophan on self-mutilation in the Lesch-Nyhan syndrome. Neuropadiatrie, 6(1), 13–23.
Moreno-Fuenmayor, H., Borjas, L., Arrieta, A., Valera, V., & Socorro-Candanoza, L. (1996). Plasma excitatory amino acids in autism. Investigacion Clinica, 37(2), 113–128.PubMed
Morgan, J. R., Storch, E. A., Woods, D. W., Bodzin, D., Lewin, A. B., & Murphy, T. K. (2010). A preliminary analysis of the phenomenology of skin-picking in Prader-Willi syndrome. Child Psychiatry and Human Development, 41(4), 448–463.PubMed
Mori, T., Ito, S., Kita, T., Narita, M., Suzuki, T., Matsubayashi, K., et al. (2007). Oxidative stress in methamphetamine-induced self-injurious behavior in mice. Behavioural Pharmacology, 18(3), 239–249.PubMed
Mori, T., Ito, S., Kita, T., & Sawaguchi, T. (2004). Effects of dopamine- and serotonin-related compounds on methamphetamine-induced self-injurious behavior in mice. Journal of Pharmacological Sciences, 96(4), 459–464.PubMed
Muehlmann, A. M., Brown, B. D., & Devine, D. P. (2008). Pemoline (2-amino-5-phenyl-1,3-oxazol-4-one)-induced self-injurious behavior: A rodent model of pharmacotherapeutic efficacy. The Journal of Pharmacology and Experimental Therapeutics, 324(1), 214–223.PubMed
Muehlmann, A. M., & Devine, D. P. (2008). Glutamate-mediated neuroplasticity in an animal model of self-injurious behaviour. Behavioural Brain Research, 189(1), 32–40.PubMed
Muehlmann, A. M., Kies, S. D., Turner, C. A., Wolfman, S., Lewis, M. H., & Devine, D. P. (2012). Self-injurious behaviour: Limbic dysregulation and stress effects in an animal model. Journal of Intellectual Disability Research, 56(5), 490–500.PubMed
Muehlmann, A. M., Wilkinson, J. A., & Devine, D. P. (2011). Individual differences in vulnerability for self-injurious behavior: Studies using an animal model. Behavioural Brain Research, 217(1), 148–154.PubMedCentralPubMed
Novak, M. A. (2003). Self-injurious behavior in rhesus monkeys: New insights into its etiology, physiology, and treatment. American Journal of Primatology, 59(1), 3–19.PubMed
Nyhan, W. L. (1972). Behavioral phenotypes in organic genetic disease: Presidential address to the Society for Pediatric Research, May 1, 1971. Pediatric Research, 6(1), 1–9.PubMed
Nyhan, W. L. (1973). The Lesch-Nyhan syndrome. Annual Review of Medicine, 24, 41–60.PubMed
Nyhan, W. L. (1997). The recognition of Lesch-Nyhan syndrome as an inborn error of purine metabolism. Journal of Inherited Metabolic Disease, 20(2), 171–178.PubMed
Nyhan, W. L., Johnson, H. G., Kaufman, I. A., & Jones, K. L. (1980). Serotonergic approaches to the modification of behavior in the Lesch-Nyhan syndrome. Applied Research in Mental Retardation, 1(1), 25–40.PubMed
Oblak, A., Gibbs, T. T., & Blatt, G. J. (2009). Decreased GABAA receptors and benzodiazepine binding sites in the anterior cingulate cortex in autism. Autism Research, 2(4), 205–219.PubMedCentralPubMed
Oliver, C., Sloneem, J., Hall, S., & Arron, K. (2009). Self-injurious behaviour in Cornelia de Lange syndrome: 1. Prevalence and phenomenology. Journal of Intellectual Disability Research, 53(7), 575–589.PubMed
Oltras, C. M., Mora, F., & Vives, F. (1987). Beta-endorphin and ACTH in plasma: Effects of physical and psychological stress. Life Sciences, 40(17), 1683–1686.PubMed
Orr, R. (1993). Age-related changes in stress experienced by families with a child who has developmental delays. Mental Retardation, 31(3), 171–176.PubMed
Osman, O. T., & Loschen, E. L. (1992). Self-injurious behavior in the developmentally disabled: Pharmacologic treatment. Psychopharmacology Bulletin, 28(4), 439–449.PubMed
Overhauser, J., Huang, X., Gersh, M., Wilson, W., McMahon, J., Bengtsson, U., et al. (1994). Molecular and phenotypic mapping of the short arm of chromosome 5: Sublocalization of the critical region for the cri-du-chat syndrome. Human Molecular Genetics, 3(2), 247–252.PubMed
Owen, R., Sikich, L., Marcus, R. N., Corey-Lisle, P., Manos, G., McQuade, R. D., et al. (2009). Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics, 124(6), 1533–1540.PubMed
Parikh, M. S., Kolevzon, A., & Hollander, E. (2008). Psychopharmacology of aggression in children and adolescents with autism: A critical review of efficacy and tolerability. Journal of Child and Adolescent Psychopharmacology, 18(2), 157–178.PubMed
Patel, N. C., Crismon, M. L., Hoagwood, K., Johnsrud, M. T., Rascati, K. L., Wilson, J. P., et al. (2005). Trends in the use of typical and atypical antipsychotics in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 44(6), 548–556.PubMed
Peebles, K. A., & Price, T. J. (2012). Self-injurious behaviour in intellectual disability syndromes: Evidence for aberrant pain signalling as a contributing factor. Journal of Intellectual Disability Research, 56(5), 441–452.PubMedCentralPubMed
Pfeffer, C. R., Jiang, H., & Domeshek, L. J. (1997). Buspirone treatment of psychiatrically hospitalized prepubertal children with symptoms of anxiety and moderately severe aggression. Journal of Child and Adolescent Psychopharmacology, 7(3), 145–155.PubMed
Piazza, C. C., Adelinis, J. D., Hanley, G. P., Goh, H., & Delia, M. D. (2000). An evaluation of the effects of matched stimuli on behaviors maintained by automatic reinforcement. Journal of Applied Behavior Analysis, 33(1), 13–27.PubMedCentralPubMed
Piazza, C. C., Fisher, W. W., & Kahng, S. W. (1996). Sleep patterns in children and young adults with mental retardation and severe behavior disorders. Developmental Medicine and Child Neurology, 38(4), 335–344.PubMed
Politte, L. C., & McDougle, C. J. (2014). Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders. Psychopharmacology (Berl), 231(6), 1023–1036.
Posey, D. J., Stigler, K. A., Erickson, C. A., & McDougle, C. J. (2008). Antipsychotics in the treatment of autism. Journal of Clinical Investigation, 118(1), 6–14.PubMedCentralPubMed
Potenza, M. N., Holmes, J. P., Kanes, S. J., & McDougle, C. J. (1999). Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study. Journal of Clinical Psychopharmacology, 19(1), 37–44.PubMed
Privitera, M. D. (1997). Topiramate: A new antiepileptic drug. The Annals of Pharmacotherapy, 31(10), 1164–1173.PubMed
Quine, L. (1991). Sleep problems in children with mental handicap. Journal of Mental Deficiency Research, 35(4), 269–290.PubMed
Quine, S. (1993). Stressors experienced by relatives of patients in an innovative rehabilitation program. Health and Social Work, 18(2), 114–122.PubMed
Ratey, J. J., Sovner, R., Mikkelsen, E., & Chmielinski, H. E. (1989). Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons. The Journal of Clinical Psychiatry, 50(10), 382–384.PubMed
Reisberg, B., & Gershon, S. (1979). Side effects associated with lithium therapy. Archives of General Psychiatry, 36(8), 879–887.PubMed
Riblet, L. A., Taylor, D. P., Elson, M. S., & Stanton, H. C. (1982). Pharmacology and neurochemistry of buspirone. Journal of Clinical Psychiatry, 43(12), 11–16.PubMed
Richardson, J. S., & Zaleski, W. A. (1983). Naloxone and self-mutilation. Biological Psychiatry, 18(1), 99–101.PubMed
Richman, D. M., Barnard-Brak, L., Bosch, A., Thompson, S., Grubb, L., & Abby, L. (2013). Predictors of self-injurious behaviour exhibited by individuals with autism spectrum disorder. Journal of Intellectual Disability Research, 57(5), 429–439.PubMed
Ricketts, R. W., Goza, A. B., Ellis, C. R., Singh, Y. N., Chambers, S., Singh, N. N., et al. (1994). Clinical effects of buspirone on intractable self-injury in adults with mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry, 33(2), 270–276.PubMed
Roach, E. S., Delgado, M., Anderson, L., Iannaccone, S. T., & Burns, D. K. (1996). Carbamazepine trial for Lesch-Nyhan self-mutilation. Journal of Child Neurology, 11(6), 476–478.PubMed
Roby-Brami, A., Bussel, B., Willer, J. C., & Le Bars, D. (1987). An electrophysiological investigation into the pain-relieving effects of heterotopic nociceptive stimuli: Probable involvement of a supraspinal loop. Brain, 110(6), 1497–1508.PubMed
Rohatgi, S., Clark, D., Kline, A. D., Jackson, L. G., Pie, J., Siu, V., et al. (2010). Facial diagnosis of mild and variant CdLS: Insights from a dysmorphologist survey. American Journal of Medical Genetics, 152A(7), 1641–1653.PubMed
Rojahn, J., Wilkins, J., Matson, J. L., & Boisjoli, J. (2010). A comparison of adults with intellectual disabilities with and without ASD on parallel measures of challenging behaviour: The behavior problems inventory-01 (BPI-01) and Autism spectrum disorders-behavior problems for intellectually disabled adults (ASD-BPA). Journal of Applied Research in Intellectual Disabilities, 23(2), 179–185.
Ruedrich, S., Swales, T. P., Fossaceca, C., Toliver, J., & Rutkowski, A. (1999). Effect of divalproex sodium on aggression and self-injurious behaviour in adults with intellectual disability: A retrospective review. Journal of Intellectual Disability Research, 43(2), 105–111.PubMed
Ruedrich, S. L., Swales, T. P., Rossvanes, C., Diana, L., Arkadiev, V., & Lim, K. (2008). Atypical antipsychotic medication improves aggression, but not self-injurious behaviour, in adults with intellectual disabilities. Journal of Intellectual Disability Research, 52(2), 132–140.PubMed
Saito, Y., & Takashima, S. (2000). Neurotransmitter changes in the pathophysiology of Lesch-Nyhan syndrome. Brain and Development, 22, S122–S131.PubMed
Sampat, R., Fu, R., Larovere, L. E., Torres, R. J., Ceballos-Picot, I., Fischbach, M., et al. (2011). Mechanisms for phenotypic variation in Lesch-Nyhan disease and its variants. Human Genetics, 129(1), 71–78.PubMedCentralPubMed
Sandman, C. A., Barron, J. L., Chicz-DeMet, A., & DeMet, E. M. (1990). Plasma B-endorphin levels in patients with self-injurious behavior and stereotypy. American Journal of Mental Retardation, 95(1), 84–92.PubMed
Sandman, C. A., Datta, P. C., Barron, J., Hoehler, F. K., Williams, C., & Swanson, J. M. (1983). Naloxone attenuates self-abusive behavior in developmentally disabled clients. Applied Research in Mental Retardation, 4(1), 5–11.PubMed
Sandman, C. A., Hetrick, W., Taylor, D. V., & Chicz-DeMet, A. (1997). Dissociation of POMC peptides after self-injury predicts responses to centrally acting opiate blockers. American Journal of Mental Retardation, 102(2), 182–199.PubMed
Sandman, C. A., Spence, M. A., & Smith, M. (1999). Proopiomelanocortin (POMC) disregulation and response to opiate blockers. Mental Retardation and Developmental Disabilities Research Reviews, 5(4), 314–321.
Sandman, C. A., Touchette, P. E., Marion, S. D., & Chicz-DeMet, A. (2008). The role of proopiomelanocortin (POMC) in sequentially dependent self-injurious behavior. Developmental Psychobiology, 50(7), 680–689.PubMedCentralPubMed
Sassi, R. B., & Soares, J. C. (2002). Neural circuitry and signaling in bipolar disorder. In G. B. Kaplan & R. P. Hammer (Eds.), Brain circuitry and signaling in psychiatry (pp. 179–200). Washington, DC: American Psychiatric Publishing Inc.
Scahill, L., Aman, M. G., McDougle, C. J., Arnold, L. E., McCracken, J. T., Handen, B., et al. (2009). Trial design challenges when combining medication and parent training in children with pervasive developmental disorders. Journal of Autism and Developmental Disorders, 39(5), 720–729.PubMed
Schain, R. J., & Freedman, D. X. (1961). Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. The Journal of Pediatrics, 58, 315–320.PubMed
Schroeder, S. R., Oster-Granite, M. L., Berkson, G., Bodfish, J. W., Breese, G. R., Cataldo, M. F., et al. (2001). Self-injurious behavior: Gene–brain–behavior relationships. Mental Retardation and Developmental Disabilities Research Reviews, 7(1), 3–12.PubMed
Schroeder, S. R., Schroeder, C. S., Smith, B., & Dalldorf, J. (1978). Prevalence of self-injurious behaviors in a large state facility for the retarded: A three-year follow-up study. Journal of Autism and Childhood Schizophrenia, 8(3), 261–269.PubMed
Shakya, D. R., Shyangwa, P. M., Pandey, A. K., Subedi, S., & Yadav, S. (2010). Self injurious behavior in temporal lobe epilepsy. Journal of the Nepal Medical Association, 49(179), 239–242.PubMed
Shapira, N. A., Lessig, M. C., Murphy, T. K., Driscoll, D. J., & Goodman, W. K. (2002). Topiramate attenuates self-injurious behaviour in Prader-Willi syndrome. The International Journal of Neuropsychopharmacology, 5(2), 141–145.PubMed
Shinohe, A., Hashimoto, K., Nakamura, K., Tsujii, M., Iwata, Y., Tsuchiya, K. J., et al. (2006). Increased serum levels of glutamate in adult patients with autism. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 30(8), 1472–1477.PubMed
Siegel, M., Milligan, B., Robbins, D., & Prentice, G. (2012). Electroconvulsive therapy in an adolescent with autism and bipolar I disorder. The Journal of ECT, 28(4), 252–255.PubMed
Sigafoos, J., O’Reilly, M., Ma, C. H., Edrisinha, C., Cannella, H., & Lancioni, G. E. (2006). Effects of embedded instruction versus discrete-trial training on self-injury, correct responding, and mood in a child with autism. Journal of Intellectual and Developmental Disability, 31(4), 196–203.PubMed
Simeon, D., Stein, D. J., Gross, S., Islam, N., Schmeidler, J., & Hollander, E. (1997). A double-blind trial of fluoxetine in pathologic skin picking. The Journal of Clinical Psychiatry, 58(8), 341–347.PubMed
Singh, N. N., & Aman, M. G. (1981). Effects of thioridazine dosage on the behavior of severely mentally retarded persons. American Journal of Mental Deficiency, 85(6), 580–587.PubMed
Skinner, B. F. (1938). The behavior of organisms: An experimental analysis. Oxford, England: Appleton-Century.
Smith, R. G. (2011). Developing antecedent interventions for problem behavior. In W. W. Fisher, C. C. Piazza, & H. S. Roane (Eds.), Handbook of applied behavior analysis (pp. 297–316). New York: Guilford Press.
Snyder, R., Turgay, A., Aman, M., Binder, C., Fisman, S., & Carroll, A. (2002). Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. Journal of the American Academy of Child and Adolescent Psychiatry, 41(9), 1026–1036.PubMed
Sohanpal, S. K., Deb, S., Thomas, C., Soni, R., Lenotre, L., & Unwin, G. (2007). The effectiveness of antidepressant medication in the management of behaviour problems in adults with intellectual disabilities: A systematic review. Journal of Intellectual Disability Research, 51(10), 750–765.PubMed
Sovner, R. (1986). Limiting factors in the use of DSM-III criteria with mentally ill/mentally retarded persons. Psychopharmacology Bulletin, 22(4), 1055–1059.PubMed
Sovner, R., Fox, C. J., Lowry, M. J., & Lowry, M. A. (1993). Fluoxetine treatment of depression and associated self-injury in two adults with mental retardation. Journal of Intellectual Disability Research, 37(3), 301–311.PubMed
Sprague, J. R., & Horner, R. H. (1995). Functional assessment and intervention in community settings. Mental Retardation and Developmental Disabilities Research Reviews, 1(2), 89–93.
Sprague, R. L., & Werry, J. S. (1971). Methodology of psychopharmacological studies with the retarded. International Review of Research in Mental Retardation, 5, 147–219.
Stein, D. J., Keating, J., Zar, H. J., & Hollander, E. (1994). A survey of the phenomenology and pharmacotherapy of compulsive and impulsive-aggressive symptoms in Prader-Willi syndrome. The Journal of Neuropsychiatry and Clinical Neurosciences, 6(1), 23–29.PubMed
Sterling-Turner, H. E., & Jordan, S. S. (2007). Interventions addressing transition difficulties for individuals with autism. Psychology in the Schools, 44(7), 681–690.
Stigler, K. A., Diener, J. T., Kohn, A. E., Li, L., Erickson, C. A., Posey, D. J., et al. (2009). Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger’s disorder: A 14-week, prospective, open-label study. Journal of Child and Adolescent Psychopharmacology, 19(3), 265–274.PubMedCentralPubMed
Stigler, K. A., Potenza, M. N., Posey, D. J., & McDougle, C. J. (2004). Weight gain associated with atypical antipsychotic use in children and adolescents: Prevalence, clinical relevance, and management. Pediatric Drugs, 6(1), 33–44.PubMed
Stout, R. J. (1990). Fluoxetine for the treatment of compulsive facial picking. American Journal of Psychiatry, 147(3), 370.PubMed
Stout, J. T., & Caskey, C. T. (1985). HPRT: Gene structure, expression, and mutation. Annual Review of Genetics, 19, 127–148.PubMed
Svendsen, C. N., Froimowitz, M., Hrbek, C., Campbell, A., Kula, N., Baldessarini, R. J., et al. (1988). Receptor affinity, neurochemistry and behavioral characteristics of the enantiomers of thioridazine: Evidence for different stereoselectivities at D1 and D2 receptors in rat brain. Neuropharmacology, 27(11), 1117–1124.PubMed
Symons, F. J., Butler, M. G., Sanders, M. D., Feurer, I. D., & Thompson, T. (1999). Self-injurious behavior and Prader-Willi syndrome: Behavioral forms and body locations. American Journal of Mental Retardation, 104(3), 260–269.PubMed
Symons, F. J., & Danov, S. E. (2005). A prospective clinical analysis of pain behavior and self-injurious behavior. Pain, 117(3), 473–477.PubMed
Tate, B. G., & Baroff, G. S. (1973). Aversive control of self-Injurious behavior in a psychotic boy. In J. M. Stedman, W. F. Patton, & K. F. Walton (Eds.), Clinical studies in behavior therapy with children, adolescents and their families (pp. 352–360). Springfield, IL: Charles C. Thomas Publisher.
Taylor, D. V., Rush, D., Hetrick, W. P., & Sandman, C. A. (1993). Self-injurious behavior within the menstrual cycle of women with mental retardation. American Journal of Mental Retardation, 97(6), 659–664.PubMed
Thompson, R. H., & Borrero, J. C. (2011). Direct observation. In W. W. Fisher, C. C. Piazza, & H. S. Roane (Eds.), Handbook of applied behavior analysis (pp. 191–205). New York: Guilford Press.
Tiefenbacher, S., Novak, M. A., Lutz, C. K., & Meyer, J. S. (2005). The physiology and neurochemistry of self-injurious behavior: A nonhuman primate model. Frontiers in Bioscience, 10, 1–11.PubMed
Tsiouris, J. A., Cohen, I. L., Patti, P. J., & Korosh, W. M. (2003). Treatment of previously undiagnosed psychiatric disorders in persons with developmental disabilities decreased or eliminated self-injurious behavior. The Journal of Clinical Psychiatry, 64(9), 1081–1090.PubMed
Tyrer, S. P., Walsh, A., Edwards, D. E., Berney, T. P., & Stephens, D. A. (1984). Factors associated with a good response to lithium in aggressive mentally handicapped subjects. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 8(4), 751–755.PubMed
Van der Zee, S. P., Schretlen, E. D., & Monnens, L. A. (1968). Megaloblastic anaemia in the Lesch-Nyhan syndrome. Lancet, 1(7557), 1427.PubMed
Van Erp, A. M., & Miczek, K. A. (2000). Aggressive behavior, increased accumbal dopamine, and decreased cortical serotonin in rats. Journal of Neuroscience, 20(24), 9320–9325.PubMed
Vandenbergh, D. J., Persico, A. M., Hawkins, A. L., Griffin, C. A., Li, X., Jabs, E. W., et al. (1992). Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics, 14(4), 1104–1106.PubMed
Veenstra-VanderWeele, J., & Anderson, G. M. (2011). The serotonin system in autism. In E. Hollander, A. Kolevzon, & J. T. Coyle (Eds.), Textbook of autism spectrum disorders (pp. 315–322). Washington, DC: American Psychiatric Publishing Inc.
Vestergaard, P., Amdisen, A., & Schou, M. (1980). Clinically significant side effects of lithium treatment: A survey of 237 patients in long-term treatment. Acta Psychiatrica Scandinavica, 62(3), 193–200.PubMed
Vollmer, T. R., Iwata, B. A., Zarcone, J. R., & Smith, R. G. (1993). The role of attention in the treatment of attention-maintained self-injurious behavior: Noncontingent reinforcement and differential reinforcement of other behavior. Journal of Applied Behavior Analysis, 26(1), 9–21.PubMedCentralPubMed
Vollmer, T. R., Marcus, B. A., & LeBlanc, L. (1994). Treatment of self-injury and hand mouthing following inconclusive functional analyses. Journal of Applied Behavior Analysis, 27(2), 331–344.PubMedCentralPubMed
Wachtel, L. E., Contrucci-Kuhn, S. A., Griffin, M., Thompson, A., Dhossche, D. M., & Reti, I. M. (2009). ECT for self-injury in an autistic boy. European Child and Adolescent Psychiatry, 18(7), 458–463.PubMed
Wachtel, L. E., & Dhossche, D. M. (2010). Self-injury in autism as an alternate sign of catatonia: Implications for electroconvulsive therapy. Medical Hypotheses, 75(1), 111–114.PubMed
Wachtel, L. E., Griffin, M., & Reti, I. M. (2010). Electroconvulsive therapy in a man with autism experiencing severe depression, catatonia, and self-injury. The Journal of ECT, 26(1), 70–73.PubMed
Wallis, C. (2009). Respiratory health of people with profound intellectual and multiple disabilities. In J. Pawlyn & S. Carnaby (Eds.), Profound intellectual and multiple disabilities: Nursing complex needs (pp. 186–201). Hoboken: Wiley.
Walters, A. S., Barrett, R. P., Feinstein, C., Mercurio, A., & Hole, W. T. (1990). A case report of naltrexone treatment of self-injury and social withdrawal in autism. Journal of Autism and Developmental Disorders, 20(2), 169–176.PubMed
Watt-Smith, P. (2009). Dental care and oral health. In J. Pawlyn & S. Carnaby (Eds.), Profound intellectual and multiple disabilities: Nursing complex needs (pp. 202–235). Hoboken: Wiley.
West, S. A., Keck, P. E., & Mcelroy, S. L. (1995). Oral loading doses in the valproate treatment of adolescents with mixed bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 5(3), 225–231.
Willemsen-Swinkels, S. H., Buitelaar, J. K., Nijhof, G. J., & van Engeland, H. (1995). Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies. Archives of General Psychiatry, 52(9), 766–773.PubMed
Willer, J. C., Dehen, H., & Cambier, J. (1981). Stress-induced analgesia in humans: Endogenous opioids and naloxone-reversible depression of pain reflexes. Science, 212(4495), 689–691.PubMed
Williams, K., Wheeler, D. M., Silove, N., & Hazell, P. (2010). Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database of Systematic Reviews, (8), CD004677. doi:10.​1002/​14651858.​CD004677.​pub2.
Wilson, J. M., Young, A. B., & Kelley, W. N. (1983). Hypoxanthine-guanine phosphoribosyltransferase deficiency. The molecular basis of the clinical syndromes. The New England Journal of Medicine, 309(15), 900–910.PubMed
Wink, L. K., Erickson, C. A., & McDougle, C. J. (2010). Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders. Current Treatment Options in Neurology, 12(6), 529–538.PubMed
Wolff, J. J., Hazlett, H. C., Lightbody, A. A., Reiss, A. L., & Piven, J. (2013). Repetitive and self-injurious behaviors: Associations with caudate volume in autism and fragile X syndrome. Journal of Neurodevelopmental Disorders, 5(1), 12.PubMedCentralPubMed
Wong, D. F., Harris, J. C., Naidu, S., Yokoi, F., Marenco, S., Dannals, R. F., et al. (1996). Dopamine transporters are markedly reduced in Lesch-Nyhan disease in vivo. Proceedings of the National Academy of Sciences of the United States of America, 93(11), 5539–5543.PubMedCentralPubMed
Zhang, W., & Bymaster, F. P. (1999). The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors. Psychopharmacology (Berl), 141(3), 267–278.
Metagegevens
Titel
Multidisciplinary Assessment and Treatment of Self-Injurious Behavior in Autism Spectrum Disorder and Intellectual Disability: Integration of Psychological and Biological Theory and Approach
Auteurs
Noha F. Minshawi
Sarah Hurwitz
Danielle Morriss
Christopher J. McDougle
Publicatiedatum
01-06-2015
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 6/2015
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-014-2307-3

Andere artikelen Uitgave 6/2015

Changes in Prevalence of Autism Spectrum Disorders in 2001–2011: Findings from the Stockholm Youth Cohort

  • Original Paper

Improving Psychosexual Knowledge in Adolescents with Autism Spectrum Disorder: Pilot of the Tackling Teenage Training Program

  • Original Paper

Maternal Smoking and Autism Spectrum Disorder: A Meta-analysis

  • Original Paper

Brief Report: Phenotypic Differences and their Relationship to Paternal Age and Gender in Autism Spectrum Disorder

  • Brief Report

The Screening Accuracy of the Parent and Teacher-Reported Social Responsiveness Scale (SRS): Comparison with the 3Di and ADOS

  • Original Paper

Effectiveness of Community-Based Early Intervention Based on Pivotal Response Treatment

  • Original Paper